Cardiovascular outcomes in type 1 and type 2 diabetes

被引：0
|
作者：
Annika Rosengren
Pigi Dikaiou
机构：
[1] University of Gothenburg,Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy
[2] Sahlgrenska University Hospital,Region Västra Götaland, Department of Medicine, Geriatrics and Emergency Medicine
[3] Östra Hospital,Department of Endocrinology
[4] Sahlgrenska University Hospital,undefined
来源：
Diabetologia | 2023年 / 66卷
关键词：
Cardiovascular disease; Glycaemic control; Review; Risk factors; Type 1 diabetes; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 437
页数：12
相关论文
共 50 条
  • [1] Cardiovascular outcomes in type 1 and type 2 diabetes
    Rosengren, Annika
    Dikaiou, Pigi
    [J]. DIABETOLOGIA, 2023, 66 (03) : 425 - 437
  • [2] Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes
    Chi, Cecilia
    Snaith, Jennifer
    Gunton, Jenny E.
    [J]. HEART LUNG AND CIRCULATION, 2017, 26 (11): : 1133 - 1141
  • [3] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Cohen, Scott
    Beckey, Cherylyn
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18): : 1797 - 1797
  • [4] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Singh, Sonal
    Furberg, Curt D.
    [J]. HEART, 2009, 95 (01) : 1 - 3
  • [5] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
    Wiviott, S. D.
    Raz, I.
    Bonaca, M. P.
    Mosenzon, O.
    Kato, E. T.
    Cahn, A.
    Silverman, M. G.
    Zelniker, T. A.
    Kuder, J. F.
    Murphy, S. A.
    Bhatt, D. L.
    Leiter, L. A.
    McGuire, D. K.
    Wilding, J. P. H.
    Ruff, C. T.
    Gause-Nilsson, I. A. M.
    Fredriksson, M.
    Johansson, P. A.
    Langkilde, A-M.
    Sabatine, M. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 347 - 357
  • [6] Canagliflozin and cardiovascular outcomes in Type 2 diabetes
    Sarraju, Ashish
    Spencer-Bonilla, Gabriela
    Rodriguez, Fatima
    Mahaffey, Kenneth W.
    [J]. FUTURE CARDIOLOGY, 2020, 17 (01) : 39 - 48
  • [7] Empagliflozin and cardiovascular outcomes in type 2 diabetes
    Gregory B. Lim
    [J]. Nature Reviews Cardiology, 2016, 13 (1) : 3 - 3
  • [8] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Grant, P. J.
    [J]. HEART, 2009, 95 (04) : 332 - 332
  • [9] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Marso, Steven P.
    Daniels, Gilbert H.
    Brown-Frandsen, Kirstine
    Kristensen, Peter
    Mann, Johannes F. E.
    Nauck, Michael A.
    Nissen, Steven E.
    Pocock, Stuart
    Poulter, Neil R.
    Ravn, Lasse S.
    Steinberg, William M.
    Stockner, Mette
    Zinman, Bernard
    Bergenstal, Richard M.
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 311 - 322
  • [10] Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
    Cannon, Christopher P.
    Pratley, Richard
    Dagogo-Jack, Samuel
    Mancuso, James
    Huyck, Susan
    Masiukiewicz, Urszula
    Charbonnel, Bernard
    Frederich, Robert
    Gallo, Silvina
    Cosentino, Francesco
    Shih, Weichung J.
    Gantz, Ira
    Terra, Steven G.
    Cherney, David Z. I.
    McGuire, Darren K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1425 - 1435
12345